Sympathetic nervous modulation of the skin innate and adaptive immune response to peptidoglycan but not lipopolysaccharide: Involvement of β-adrenoceptors and relevance in inflammatory diseases

Asselin-Paturel, 2005, Type I interferon dependence of plasmacytoid dendritic cell activation and migration, J. Exp. Med., 201, 1157, 10.1084/jem.20041930 Chan, 2006, IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis, J. Exp. Med., 203, 2577, 10.1084/jem.20060244 Chen, 2002, Beta-adrenergic receptor activation inhibits keratinocyte migration via a cyclic adenosine monophosphate-independent mechanism, J. Invest. Dermatol., 119, 1261, 10.1046/j.1523-1747.2002.19611.x Chow, 2005, The role of T cells in cutaneous autoimmune disease, Autoimmunity, 38, 303, 10.1080/08916930500124429 Chuh, 2006, The skin and the mind, Aust. Fam. Physician, 35, 723 Dziarski, 2005, Peptidoglycan recognition in innate immunity, J. Endotoxin Res., 11, 304, 10.1177/09680519050110050801 Dziarski, 2005, Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation, Infect. Immun., 73, 5212, 10.1128/IAI.73.8.5212-5216.2005 Elenkov, 2000, The sympathetic nerve—an integrative interface between two supersystems: the brain and the immune system, Pharmacol. Rev., 52, 595 Faure, 2000, Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells, J. Biol. Chem., 275, 11058, 10.1074/jbc.275.15.11058 Halevy, 1993, Beta-adrenergic blocking drugs and psoriasis: the role of an immunologic mechanism, J. Am. Acad. Dermatol., 29, 504, 10.1016/S0190-9622(08)82012-9 Hodl, 1985, Side effects of beta receptor blockers on the skin. Review and personal observations, Hautarzt, 36, 549 Jawdat, 2006, Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan, J. Immunol., 177, 1755, 10.4049/jimmunol.177.3.1755 Kang, 2006, Toll-like receptors: applications to dermatologic disease, J. Am. Acad. Dermatol., 54, 951, 10.1016/j.jaad.2005.05.004 Kay, 2005, Mast cell beta2-adrenoceptors, Chem. Immunol. Allergy, 87, 145, 10.1159/000087641 Kohrgruber, 2004, Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands, J. Immunol., 173, 6592, 10.4049/jimmunol.173.11.6592 Kroemer, 1996, Differential involvement of Th1 and Th2 cytokines in autoimmune diseases, Autoimmunity, 24, 25, 10.3109/08916939608995354 Lavoie, 2003, Pharmacological characterization of putative beta1–beta2-adrenergic receptor heterodimers, Can. J. Physiol. Pharmacol., 81, 186, 10.1139/y02-167 Maestroni, 2000, Dendritic cell migration controlled by alpha 1b-adrenergic receptors, J. Immunol., 165, 6743, 10.4049/jimmunol.165.12.6743 Maestroni, 2002, Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development, J. Neuroimmunol., 129, 106, 10.1016/S0165-5728(02)00188-1 Maestroni, 2002, Short exposure of antigen-stimulated dendritic cells to norepinephrine: impact on kinetic of cytokine production and Th polarization, J. Neuroimmunol., 129, 106, 10.1016/S0165-5728(02)00188-1 Maestroni, 2006, Sympathetic nervous system influence on the innate immune response, Ann. N. Y. Acad. Sci., 1069, 195, 10.1196/annals.1351.017 Maestroni, 2003, Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity, J. Neuroimmunol., 144, 91, 10.1016/j.jneuroim.2003.08.039 Nestle, 2005, Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production, J. Exp. Med., 202, 135, 10.1084/jem.20050500 Novak, 2005, The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis, J. Am. Acad. Dermatol., 53, S171, 10.1016/j.jaad.2005.04.060 Ouyang, 2007, Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation, Biochem. Biophys. Res. Commun., 354, 1045, 10.1016/j.bbrc.2007.01.090 Palframan, 2001, Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues, J. Exp. Med., 194, 1361, 10.1084/jem.194.9.1361 Palsson-McDermott, 2004, Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4, Immunology, 113, 153, 10.1111/j.1365-2567.2004.01976.x Sandor, 2005, Toll-like receptors. II. Distribution and pathways involved in TLR signalling, Folia Biol. (Praha), 51, 188 Schallreuter, 1997, Epidermal adrenergic signal transduction as part of the neuronal network in the human epidermis, J. Investig. Dermatol. Symp. Proc., 2, 37, 10.1038/jidsymp.1997.9 Seiffert, 2002, Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells, J. Immunol., 168, 6128, 10.4049/jimmunol.168.12.6128 Sigola, 2000, Adrenaline inhibits macrophage nitric oxide production through beta1 and beta2 adrenergic receptors, Immunology, 100, 359, 10.1046/j.1365-2567.2000.00029.x Steinkraus, 1993, Beta-adrenergic receptors in psoriasis: evidence for down-regulation in lesional skin, Arch. Dermatol. Res., 285, 300, 10.1007/BF00371601 Sternberg, 2006, Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens, Nat. Rev. Immunol., 6, 318, 10.1038/nri1810 Supajatura, 2002, Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity, J. Clin. Invest., 109, 1351, 10.1172/JCI0214704 Takeda, 2005, Evolution and integration of innate immune recognition systems: the Toll-like receptors, J. Endotoxin Res., 11, 51, 10.1177/09680519050110011101 Takeda, 2003, Toll-like receptors, Annu. Rev. Immunol., 21, 335, 10.1146/annurev.immunol.21.120601.141126 Tomi, 2005, Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects, J. Am. Acad. Dermatol., 53, 67, 10.1016/j.jaad.2005.02.034 Toshchakov, 2002, TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages, Nat. Immunol., 3, 392, 10.1038/ni774 Valladeau, 2005, Cutaneous dendritic cells, Semin. Immunol., 17, 273, 10.1016/j.smim.2005.05.009 Yoshida, 1996, Effects of beta-blockers on HMG CoA reductase and LDL receptor activity in cultured human skin fibroblasts, Cardiovasc. Drugs Ther., 10, 67, 10.1007/BF00051132